CIK 0000805928 · Large accelerated filer
Axogen, Inc.
Sign in to watch- Ticker
- AXGN
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- EIN
- 411301878
- Phone
- (386) 462-6817
- Business address
- 13631 PROGRESS BLVD., SUITE 400, ALACHUA, FL, 32615
- Former names
- LECTEC CORP /MN/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $173,940
- in 1 filing, $174K under 10b5-1 plans
Net −$173,940. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-06-01 | Rudelius Robert James Director | Grant or award · Stock Option (right to purchase) | +15,000 | 15,000 | ||
| 2017-06-01 | Gold Mark Stephen Director | Grant or award · Stock Option (right to purchase) | +15,000 | 15,000 | ||
| 2017-06-01 | Grooms Jamie Mark Director | Grant or award · Stock Option (right to purchase) | +15,000 | 15,000 | ||
| 2017-05-30 | Gold Mark Stephen Director | Option exercise | +5,000 | $8.95 | $45K | 345,248 |
| 2017-05-30 | Gold Mark Stephen Director | Option exercise · Stock Option (right to purchase) | −5,000 | 0 | ||
| 2017-05-22 | Gold Mark Stephen Director | Option exercise | +15,000 | $4.81 | $72K | 340,248 |
| 2017-05-22 | Gold Mark Stephen Director | Option exercise · Stock Option (right to purchase) | −15,000 | 0 | ||
| 2017-03-14 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Option exercise | +4,659 | $0.27 | $1K | 4,659 |
| 2017-03-14 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Option exercise | +359 | $0.27 | $97 | 5,018 |
| 2017-03-14 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Option exercise · Employee Stock Option (right to purchase) | +4,659 | 0 | ||
| 2017-03-14 | DeVinney Erick Wayne VP, Clinical&Translational Sc | Option exercise · Employee Stock Option (right to purchase) | +359 | 0 | ||
| 2017-03-14 | Donovan Michael Patrick VP Operations | Option exercise | +4,659 | $0.27 | $1K | 4,659 |
| 2017-03-14 | Donovan Michael Patrick VP Operations | Option exercise | +5,000 | $2.74 | $14K | 9,659 |
| 2017-03-14 | Donovan Michael Patrick VP Operations | Option exercise · Employee Stock Option (right to purchase) | +4,659 | 0 | ||
| 2017-03-14 | Donovan Michael Patrick VP Operations | Option exercise · Employee Stock Option (right to purchase) | +5,000 | 30,000 | ||
| 2016-12-30 | Freitag Gregory Gene General Counsel & SVP BD | Option exercise | +23,000 | $2.74 | $63K | 71,901 |
| 2016-12-29 | Zaderej Karen L. CEO | Grant or award | +40,000 | 282,147 | ||
| 2016-12-29 | Zaderej Karen L. CEO | Grant or award · Employee Stock Option (right to purchase) | +209,500 | 209,500 | ||
| 2016-12-29 | Freitag Gregory Gene General Counsel & SVP BD | Grant or award · Employee Stock Option (right to purchase) | +50,000 | 50,000 | ||
| 2016-12-29 | NEELS GUIDO J Director | Grant or award · Stock Option (right to purchase) | +5,000 | 5,000 |
Page 59 of 61 · 1,220 trades